Global Acinetobacter Pneumonia Therapeutics Industry Overview and Current Treatment Options
Emerging Drugs for Acinetobacter PneumoniaAcinetobacter bacteria are considered an urgent threat by the CDC due to their high levels of antibiotic resistance. Treating infections caused by these bacteria, such as Acinetobacter pneumonia, has become very challenging. Currently, limited treatment options are available. However, researchers are working on developing novel drugs that could...
0 Σχόλια
0 Μοιράστηκε
English
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Russian (русский)